Xiao F - Search Results

1

PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1/C2 inhibitor PP242.

Yang C, Huang X, Liu H, Xiao F, Wei J, You L, Qian W. Yang C, et al. Among authors: xiao f. Oncotarget. 2017 Jun 13;8(24):39185-39197. doi: 10.18632/oncotarget.16642. Oncotarget. 2017. PMID: 28402933 Free PMC article.

2

Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and without hemophagocytic syndrome.

Tong H, Ren Y, Liu H, Xiao F, Mai W, Meng H, Qian W, Huang J, Mao L, Tong Y, Wang L, Qian J, Jin J. Tong H, et al. Among authors: xiao f. Leuk Lymphoma. 2008 Jan;49(1):81-7. doi: 10.1080/10428190701713630. Leuk Lymphoma. 2008. PMID: 18203016

3

[Clinical study of amphotericin B in the treatment of invasive fungal infection in 111 hematological disorder patients with neutrocytopenia].

Tong HY, Zhang FJ, Xiao F, Qian WB, Meng HT, Mai WY, Tong Y, Mao LP, Jin J. Tong HY, et al. Among authors: xiao f. Zhonghua Xue Ye Xue Za Zhi. 2008 Jul;29(7):472-5. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 19035181 Chinese.

4

Clinicopathological study on peripheral T-cell non-Hodgkin lymphoma with bone marrow involvement: a retrospective analysis from China.

Tong H, Ren Y, Qian W, Xiao F, Mai W, Meng H, Jin J. Tong H, et al. Among authors: xiao f. Int J Hematol. 2009 Oct;90(3):303-310. doi: 10.1007/s12185-009-0390-6. Epub 2009 Sep 2. Int J Hematol. 2009. PMID: 19728028

5

Massive plasmacytosis with severe marrow suppression induced by methimazole in Graves' disease patients: case report and literature review.

Xiao F, Li C, You L, Qian W, Wei J. Xiao F, et al. Int J Clin Exp Med. 2014 Oct 15;7(10):3605-8. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25419407 Free PMC article.

6

Proteasome inhibitor MG-132 enhances histone deacetylase inhibitor SAHA-induced cell death of chronic myeloid leukemia cells by an ROS-mediated mechanism and downregulation of the Bcr-Abl fusion protein.

Zhou W, Zhu W, Ma L, Xiao F, Qian W. Zhou W, et al. Among authors: xiao f. Oncol Lett. 2015 Nov;10(5):2899-2904. doi: 10.3892/ol.2015.3665. Epub 2015 Sep 2. Oncol Lett. 2015. PMID: 26722260 Free PMC article.

7

Efficacy and safety of homoharringtonine plus cytarabine and aclarubicin for patients with myelodysplastic syndrome-RAEB.

Xiao F, Li Y, Xu W, You L, Yang C, Liu H, Qian W. Xiao F, et al. Oncol Lett. 2016 Jan;11(1):355-359. doi: 10.3892/ol.2015.3876. Epub 2015 Nov 5. Oncol Lett. 2016. PMID: 26870217 Free PMC article.

8

Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia.

Huang X, Xiao F, Li Y, Qian W, Ding W, Ye X. Huang X, et al. Among authors: xiao f. J Exp Clin Cancer Res. 2018 Dec 12;37(1):310. doi: 10.1186/s13046-018-0976-z. J Exp Clin Cancer Res. 2018. PMID: 30541583 Free PMC article. Review.

9

[Clinical Features of Diffuse Large B-Cell Lymphoma Transformed from Follicular Lymphoma].

Zhang XL, Yu WJ, Zhu YN, Yang CM, Xiao F, Mai WY. Zhang XL, et al. Among authors: xiao f. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Dec;30(6):1772-1778. doi: 10.19746/j.cnki.issn.1009-2137.2022.06.022. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022. PMID: 36476902 Chinese.

10

[Clinical Characteristics and Prognosis of Patients with Primary Testicular Diffuse Large B-Cell Lymphoma].

Zhang XL, Yu WJ, Zhu YN, Xu HL, Yang CM, Xiao F, Mai WY. Zhang XL, et al. Among authors: xiao f. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Auguest;31(5):1372-1378. doi: 10.19746/j.cnki.issn.1009-2137.2023.05.019. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023. PMID: 37846687 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,016 results

Search Page

Filters